CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...